What We See for 2023: The Pharma Advertising Trends Taking Our Industry by Storm

Today’s healthcare marketers have access to more digital health data than ever. We think of that data as oil and programmatic advertising as its engine, working together to supercharge pharma advertising campaign results.

With more advancements in data and measurement, CTV’s continued explosive growth, the ever-evolving privacy landscape, and the looming death of the third-party cookie, that car is only going to keep accelerating. We’re calling it now: 2023 will be a pivotal year for pharmaceutical advertising.

But how? We posed that question to top pharma and ad-tech industry leaders from DeepIntent, our clients, and our partners.

Complete the form to receive a copy of What We See for 2023: The Pharma Advertising Trends Taking Our Industry by Storm and get a glimpse into the future.

Our Partners

Share this Post

Related Articles

 In Episode 9, host John Mangano sits down with Dr. Brad Bowman, MD, Chief Medical Officer and Head of Data Science and Quality at Healthgrades. Brad offers a unique perspective on the intersection of healthcare and artificial intelligence (AI). You may know that AI is already transforming medicine, from reading X-rays to predicting health […]

 In this episode of Deep: The Health Marketing Podcast, John Mangano is joined by Sara Hayes, SVP of Communities at Health Union. Sara oversees over 50 online health communities that connect patients with shared experiences, offering support, information, and inspiration in moments that matter most. Together, they explore: The unique role online communities play in […]

 In this episode of Deep, John Mangano sits down with Tom Carr, SVP of Media and Data Strategy at Everyday Health Group, to discuss the evolution of health marketing and its impact on consumers and providers alike. Tom shares insights from his extensive career in health media, exploring how digital platforms have transformed patient […]

Never Miss New Insights

Sign up for the newsletter to ensure our latest whitepapers, research reports, and more are delivered to your inbox.